Inogen, Inc. INGN
NASDAQ · United States · Health Technology
$5.97-0.01 (-0.17%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.14 | -0.15 | +8.7% | $95.08M | -0.2% | -7.8%$6.56→$6.05 |
| Q1 2026 | 2026-05-07 | -0.30 | -0.24 | -25.0% | — | — | -1.3%$7.11→$7.02 |
| Q4 2025 | 2026-02-24 | -0.26 | -0.36 | +27.8% | — | — | +5.8%$5.68→$6.01 |
| Q3 2025 | 2025-11-05 | -0.20 | -0.22 | +9.1% | — | — | -12.8%$8.06→$7.03 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.